142 related articles for article (PubMed ID: 19706757)
41. Association of smoking status with prognosis in bladder cancer: A meta-analysis.
Hou L; Hong X; Dai M; Chen P; Zhao H; Wei Q; Li F; Tan W
Oncotarget; 2017 Jan; 8(1):1278-1289. PubMed ID: 27902481
[TBL] [Abstract][Full Text] [Related]
42. Rare variants in BRCA2 and CHEK2 are associated with the risk of urinary tract cancers.
Ge Y; Wang Y; Shao W; Jin J; Du M; Ma G; Chu H; Wang M; Zhang Z
Sci Rep; 2016 Sep; 6():33542. PubMed ID: 27632928
[TBL] [Abstract][Full Text] [Related]
43. Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
Sankhwar M; Sankhwar SN; Bansal SK; Gupta G; Rajender S
Sci Rep; 2016 Jun; 6():27018. PubMed ID: 27246180
[TBL] [Abstract][Full Text] [Related]
44. Association of nineteen polymorphisms from seven DNA repair genes and the risk for bladder cancer in Gansu province of China.
Zhu G; Su H; Lu L; Guo H; Chen Z; Sun Z; Song R; Wang X; Li H; Wang Z
Oncotarget; 2016 May; 7(21):31372-83. PubMed ID: 27153553
[TBL] [Abstract][Full Text] [Related]
45. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors.
Kim J; Mouw KW; Polak P; Braunstein LZ; Kamburov A; Kwiatkowski DJ; Rosenberg JE; Van Allen EM; D'Andrea A; Getz G
Nat Genet; 2016 Jun; 48(6):600-606. PubMed ID: 27111033
[TBL] [Abstract][Full Text] [Related]
46. Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?
Simonds NI; Ghazarian AA; Pimentel CB; Schully SD; Ellison GL; Gillanders EM; Mechanic LE
Genet Epidemiol; 2016 Jul; 40(5):356-65. PubMed ID: 27061572
[TBL] [Abstract][Full Text] [Related]
47. Caffeine Suppresses Apoptosis of Bladder Cancer RT4 Cells in Response to Ionizing Radiation by Inhibiting Ataxia Telangiectasia Mutated-Chk2-p53 Axis.
Zhang ZW; Xiao J; Luo W; Wang BH; Chen JM
Chin Med J (Engl); 2015 Nov; 128(21):2938-45. PubMed ID: 26521794
[TBL] [Abstract][Full Text] [Related]
48. Attenuated XPC expression is not associated with impaired DNA repair in bladder cancer.
Naipal KA; Raams A; Bruens ST; Brandsma I; Verkaik NS; Jaspers NG; Hoeijmakers JH; van Leenders GJ; Pothof J; Kanaar R; Boormans J; van Gent DC
PLoS One; 2015; 10(4):e0126029. PubMed ID: 25927440
[TBL] [Abstract][Full Text] [Related]
49. Correlation between the cytology of urine sediment in fresh sample and smears stained by Papanicolaou and Giemsa methods.
Palaoro LA; Angerosa M
J Cytol; 2014 Jan; 31(1):25-31. PubMed ID: 25190980
[TBL] [Abstract][Full Text] [Related]
50. Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
Wang SS; Hsieh MJ; Ou YC; Chen CS; Li JR; Hsiao PC; Yang SF
Tumour Biol; 2014 Aug; 35(8):7483-90. PubMed ID: 24789429
[TBL] [Abstract][Full Text] [Related]
51. Genome-wide interaction study of smoking and bladder cancer risk.
Figueroa JD; Han SS; Garcia-Closas M; Baris D; Jacobs EJ; Kogevinas M; Schwenn M; Malats N; Johnson A; Purdue MP; Caporaso N; Landi MT; Prokunina-Olsson L; Wang Z; Hutchinson A; Burdette L; Wheeler W; Vineis P; Siddiq A; Cortessis VK; Kooperberg C; Cussenot O; Benhamou S; Prescott J; Porru S; Bueno-de-Mesquita HB; Trichopoulos D; Ljungberg B; Clavel-Chapelon F; Weiderpass E; Krogh V; Dorronsoro M; Travis R; Tjønneland A; Brenan P; Chang-Claude J; Riboli E; Conti D; Gago-Dominguez M; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Hohensee C; Rodabough R; Cancel-Tassin G; Roupret M; Comperat E; Chen C; De Vivo I; Giovannucci E; Hunter DJ; Kraft P; Lindstrom S; Carta A; Pavanello S; Arici C; Mastrangelo G; Karagas MR; Schned A; Armenti KR; Hosain GM; Haiman CA; Fraumeni JF; Chanock SJ; Chatterjee N; Rothman N; Silverman DT
Carcinogenesis; 2014 Aug; 35(8):1737-44. PubMed ID: 24662972
[TBL] [Abstract][Full Text] [Related]
52. Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer.
Teo MTW; Dyrskjøt L; Nsengimana J; Buchwald C; Snowden H; Morgan J; Jensen JB; Knowles MA; Taylor G; Barrett JH; Borre M; Ørntoft TF; Bishop DT; Kiltie AE
Ann Oncol; 2014 Apr; 25(4):877-883. PubMed ID: 24623370
[TBL] [Abstract][Full Text] [Related]
53. The association between the Lys751Gln polymorphism in the XPD gene and the risk of bladder cancer.
Xiong T; Yang J; Wang H; Wu F; Liu Y; Xu R; Lv Z; Xue P; Cao W; Zhang Y
Mol Biol Rep; 2014; 41(4):2629-34. PubMed ID: 24535265
[TBL] [Abstract][Full Text] [Related]
54. NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review.
Berardinelli F; di Masi A; Antoccia A
Curr Genomics; 2013 Nov; 14(7):425-40. PubMed ID: 24396275
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive analyses of DNA repair pathways, smoking and bladder cancer risk in Los Angeles and Shanghai.
Corral R; Lewinger JP; Van Den Berg D; Joshi AD; Yuan JM; Gago-Dominguez M; Cortessis VK; Pike MC; Conti DV; Thomas DC; Edlund CK; Gao YT; Xiang YB; Zhang W; Su YC; Stern MC
Int J Cancer; 2014 Jul; 135(2):335-47. PubMed ID: 24382701
[TBL] [Abstract][Full Text] [Related]
56. Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
Wang SS; Liu YF; Ou YC; Chen CS; Li JR; Yang SF
PLoS One; 2013; 8(12):e82804. PubMed ID: 24349364
[TBL] [Abstract][Full Text] [Related]
57. XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zeng RF; Long JT; Peng ZW
Tumour Biol; 2014 Jan; 35(1):447-53. PubMed ID: 23918308
[TBL] [Abstract][Full Text] [Related]
58. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
[TBL] [Abstract][Full Text] [Related]
59. Bladder cancer: a simple model becomes complex.
Di Pierro GB; Gulia C; Cristini C; Fraietta G; Marini L; Grande P; Gentile V; Piergentili R
Curr Genomics; 2012 Aug; 13(5):395-415. PubMed ID: 23372425
[TBL] [Abstract][Full Text] [Related]
60. HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.
Andrew AS; Hu T; Gu J; Gui J; Ye Y; Marsit CJ; Kelsey KT; Schned AR; Tanyos SA; Pendleton EM; Mason RA; Morlock EV; Zens MS; Li Z; Moore JH; Wu X; Karagas MR
PLoS One; 2012; 7(12):e51301. PubMed ID: 23284679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
